Navigation Links
France-Israel scientific cooperation agreement
Date:3/16/2009

Jerusalem, March 16, 2009 A French-Israeli scientific agreement, known as the European Associated Laboratory Agreement (LEA), will be signed at the Hebrew University of Jerusalem on Wednesday, March 18, within the framework of the France-Israel Binational Symposium in Neuroscience.

The new agreement marks the renewal of a 2004 joint project known as the France-Israel International Associated Laboratory Agreement, which established the Franco-Israeli Laboratory of System Neurophysiology and Neurophysics, bringing together French and Israeli researchers. The French members, from the French National Research Center (CNRS), are faculty members of Paris-Descartes University and Victor Segalen University in Bordeaux, while the Israeli researchers are senior scientists at the Hebrew University of Jerusalem.

That cooperative effort led to several collaborative joint research projects between scientists in the two countries, as well as to the first-ever French-Israeli binational neuroscience symposium -- first held in Israel in 2004 and now taking place biannually -- and to joint scientific publications.

The new agreement establishing the European Associated Laboratory (LEA), entitled the France-Israel Laboratory of Neuroscience, will be signed in the presence of President of the Hebrew University Prof. Menachem Magidor, Vice-President of the Hebrew University for Research and Development Prof. Hillel Bercovier, President of the CNRS Prof. Catherine Brechignac, and Vice-President of the Victor Segalen University Prof. Alain Blanchard. The ceremony will be held at 8:30 a.m. at the Belgium House Faculty Club on the Edmond J. Safra Campus of the Hebrew University at Givat Ram. .

"Ties with the French scientific world and especially with the large research institutions in Europe create new opportunities in brain research," said Prof. Israel Nelken of the Silberman Institute of Life Sciences at the Hebrew University and one of the leaders of the joint project. "This cooperation is especially significant in a period during which one hears voices in Europe calling for a boycott of Israeli academia."

The March 18 France-Israel Symposium in Neuroscience, to follow the agreement signing, will be held at the Konrad Adenauer Center at Mishkenot Shaananim starting at 2:15 p.m. and will feature presentations on a range of recent joint French-Israeli studies as well as topics of research and collaboration planned for coming years. The symposium is open to students and researchers who are not members of the LEA as well as members of the media.

Sponsors of the event are the France-Israel Laboratory of Neuroscience and the French Ministry of Foreign Affairs. The program will begin with remarks by Profs. l Nelken of the Hebrew University and David Hansel of the University of Paris Descartes, co-directors of the LEA, and will continue until 7:30 p.m.


'/>"/>
Contact: Jerry Barach
jerryb@savion.huji.ac.il
972-258-82904
The Hebrew University of Jerusalem
Source:Eurekalert

Related medicine news :

1. ULURU Inc. Announces Appointment of Jeffrey A. Niezgoda, M.D., as Chairman of Scientific Advisory Board
2. MedThink Hires Associate Scientific Director to Support Its Growing Health Care Clientele
3. Boston Scientific to Participate in Cowen Health Care Conference
4. IDRI Announces Appointment of Dr. Karen Auditore-Hargreaves as SVP, Scientific Affairs
5. Boston Scientific Welcomes Committee Approval of the National Pain Care Policy Act
6. Boston Scientific Announces Japanese Launch of Taxus(R) Liberte(R) Drug-Eluting Stent System
7. Boston Scientific Announces Election Of John Sununu To Its Board Of Directors
8. Traxtal to Introduce Next-Generation PercuNav System Cart at SIR Annual Scientific Meeting
9. Edmond Scientific Company Awarded VA Contract for External Integration Architecture Support
10. Society of Interventional Radiology Hosts 34th Annual Scientific Meeting
11. Avantis Medical Systems Announces Key Addition to Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... CALNOC, the nation’s first and only ... their upcoming conference – Empowerment, Value and Collaboration – in Seattle, WA on October ... the Virginia Mason Health System in Seattle since 2000. In addition to his role ...
(Date:2/23/2017)... ... February 23, 2017 , ... Curemark, LLC announced today that the Blüm ... in children aged 3-8 with Autism, is now enrolling at three new sites. These ... the United States. , “There are currently no approved drugs that address the ...
(Date:2/23/2017)... ... 23, 2017 , ... Thomas Vas-Don suffered from severe injury due ... was able to successfully recover. In “ Origin & Insertion Charts for Massage Therapists ... the principals of massage, anatomy , trigger points and referral pain patterns ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... and lobby of a new healthcare contact center in Georgia, PENETRON Specialty Products ... of the nation’s largest healthcare systems recently invested $51 million to purchase and ...
(Date:2/22/2017)... ... 22, 2017 , ... Gevir, a New Zealand-based company that focuses on developing ... coming soon to Amazon.com, the world’s largest online retailer. , The company ... an effective natural treatment for Shelley’s Multiple Sclerosis, which she’d been diagnosed with at ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... 23, 2017 Tillotts Pharma is ... Berlin office was opened in January ... The portfolio includes Entocort ® for the treatment ... of ulcerative colitis, and VistaPrep ® for bowel ... specialty pharmaceutical company focused on the treatment of gastrointestinal ...
(Date:2/23/2017)... MabVax Therapeutics Holdings, Inc . ... announces that it has received notice from the ... initiation a Phase I clinical trial with MVT-1075 ... ( 177 Lu-CHX-A?-DTPA-HuMab5B1) is the Company,s novel fully ... the phase I clinical trial in patients with ...
(Date:2/23/2017)... 2017 Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT) ( ... and dermatology biopharmaceutical company, today announced that it has ... as special advisers to the Company,s Board of ... board on financial and corporate strategy. Provectus ... of up to $2.5 million from Eric Wachter ...
Breaking Medicine Technology: